# CS10 — Adversarial review of the report

- **Type:** review — text answer (Claude Science workbench)
- **Purpose:** A skeptical, sourced peer review of the frozen report before it is treated as final. A review that finds nothing has failed.
- **Attach:** `reports/report.pdf` (pull the latest first).

## Prompt

Act as a rigorous, skeptical peer reviewer of the attached report on combinatorial surface-marker targets
for prostate cancer. Assess and be specific:

1. Is the scientific premise and the Boolean AND / NOT gate algebra sound?
2. Are the quantitative claims supported and not overstated? Point to any number that outruns its evidence.
3. Are label-leakage, assay-comparability (10x vs Smart-seq2 / chemistry), doublet handling, and
   uncertainty adequately controlled and disclosed?
4. Is the nominated pair (PSMA x STEAP1) justified given the replication finding that its coverage holds in
   AR+ adenocarcinoma but is lost in mCRPC / neuroendocrine disease?
5. Is the NOT-gate negative result interpreted correctly, or is it an artifact of the search space?
6. What controls, datasets, statistics, or citations are missing?
7. Which specific claims would you ask to be softened or retracted, and why?

Cite where you can. Return a severity-ranked list of issues, each with a concrete fix, followed by a
one-paragraph overall verdict (accept / minor revision / major revision, with the single most important
thing to fix first).

## Results

The report you've asked me to review isn't in the granted repo folders — those contain a different project (noncoding somatic drivers / TERT / saturation mutagenesis). Let me search for the prostate surface-marker report.


Ran 4 commands
4 steps

Searching repo for prostate surface-marker report
18 lines of output

Searching artifact store for prostate report
6 lines of output

Searching artifact store for the gate-logic report
20 lines of output

Enumerating all prostate artifacts
18 lines of output
The report isn't in the granted repo folders (those hold a different noncoding-driver project). It lives in this project's artifact store as a set of prostate surface-antigen files. Let me read them to find the one carrying the gate-algebra analysis, the PSMA×STEAP1 nomination, and the replication finding.


Reading surface antigen targets report
1 line
This is a literature compilation, not the quantitative gate analysis. The report you described (gate algebra, coverage/specificity numbers, 10x vs Smart-seq2, doublets, the PSMA×STEAP1 nomination with the AR+/mCRPC replication split, a NOT-gate negative) must be a computed scRNA-seq analysis. Let me read the remaining prostate artifacts.


Read 3 files
3 steps

Reading combinatorial therapies report
1 line

Reading scRNAseq datasets report
1 line

Reading antigen review
1 line
These four are supporting/literature artifacts. The core quantitative analysis they all reference — "the HuPSA analysis," coverage/specificity numbers, doublets, 10x vs Smart-seq2, the NOT-gate negative — must be a separate computed report. Let me find it.


Ran 2 commands
2 steps

Searching for the core gate-analysis report
1 line of output

Listing all project artifacts
23 lines of output
The project has more artifacts than just the "prostate_" set — there are gate-method surveys and prior review files too. But I still don't see a single consolidated "report" with the actual computed HuPSA coverage/specificity numbers, doublet handling, and the PSMA×STEAP1 nomination. Let me read the remaining candidates and check the session history for the core quantitative analysis.


Read 2 files
2 steps

Reading AND-gate methods survey
1 line

Reading target ranking stats review
1 line
I now see this is a multi-part project. target_ranking_stats_review.md is itself a prior stats review of the ranking pipeline, and prostate_antigen_review.md discusses the HuPSA PSMA×STEAP1 finding. But I need the actual computed analysis with the coverage/specificity numbers, doublet handling, assay comparison, and NOT-gate negative. Let me locate the source analysis in the session history and read the remaining pieces.


Read 2 files
2 steps · 1 failed

Reading NOT-gate blocker survey
1 line

Reading concordance table
Version not found: e9d77029-3bbf-4398-8c72-30be4f5ea62d
The concordance file wasn't found (I mistyped the ID). I've now read the survey/review layer, but the core computed analysis — the one with actual coverage/specificity numbers, the PSMA×STEAP1 nomination, the AR+ vs mCRPC/NE replication split, and the NOT-gate negative — isn't among the artifacts I've read. It's likely a frame (analysis session) or an on-disk report. Let me locate it.


Searching frames for the gate analysis
6 lines of output
These are all literature-survey subtasks feeding a larger report. The actual computed gate analysis (HuPSA scRNA-seq, coverage/specificity, doublets, replication, NOT-gate) that target_ranking_stats_review.md critiques isn't here yet. Let me search across all projects and look for the consolidated report and its analysis frame.


Global frame search for the analysis session
38 lines of output
The current project (proj_bd2a691fa4d6) contains nine literature/methods/stats subtasks but no single computed HuPSA analysis frame and no consolidated master report artifact. The "report" appears to be distributed across these artifacts. Before I review, let me confirm I'm not missing a master document and check what the current session's root actually attached.


Checking current frame and full artifact chronology
33 lines of output
There it is — report_parts.json (the assembled report) plus supporting data files (gtex, hpa, concordance, antigen_safety_review). This session is the top-level peer-review task. Let me read the consolidated report and the key data tables that back the quantitative claims.


Reading the assembled report parts
1 line
report_parts.json is the safety-review section. The core computed gate analysis — HuPSA coverage/specificity numbers, the AR+ vs mCRPC/NE replication split, doublets, 10x vs Smart-seq2, and the NOT-gate negative — lives in the statistical-validation frame that actually ran the pipeline. Let me pull that frame's transcript and the remaining data artifacts.


Read 2 files, ran a command
3 steps · 1 failed

Reading concordance table
Version not found: e9d77029-3bbf-4398-8c72-30be4f5ee62d

Reading risk reclassification
1 line

Scanning stats-validation frame for numbers
5 lines of output
The stats-validation frame message 3 (16 KB) carries the actual pipeline description and numbers. Let me read it plus the assistant's response, and fetch the concordance table with the correct ID.


Ran 2 commands, read a file
3 steps · 1 failed

Reading concordance CSV
Version not found: e9d77029-3bbf-4398-8c72-30be4f5ee62d

Extracting pipeline description from frame
21 lines of output

Reading pipeline detail message
43 lines of output
This is important: the stats-validation frame critiques a described pipeline but never ran it, and I've found no computed HuPSA analysis (no .h5ad, no coverage/specificity output tables) anywhere in the project. Let me confirm whether the "replication finding" was actually computed or is literature-inferred — that's central to the review.


Confirming whether HuPSA was computationally analyzed
45 lines of output
Confirmed — a decisive finding: there is no computed single-cell analysis anywhere in the project. No .h5ad, no scanpy pipeline, no coverage/specificity output table. The frames that mention scanpy/anndata do so only in literature discussion. Let me verify the AND-gate coverage frame is synthesis-only and check one load-bearing citation that two different artifacts attribute to two different papers.


Checking if coverage frame ran computation
11 lines of output
The coverage frame is literature-synthesis only (web searches, no single-cell computation). Now let me verify the load-bearing citation that two artifacts attribute to two different papers. Good — that resolves one concern: DOI 10.1038/s41467-023-37874-2 is Bhatia et al. 2023, Nat Commun 14:2041, the STEAP1 CAR-T paper that also reports the matched STEAP1-vs-PSMA IHC prevalence comparison. Both artifacts cite it correctly (one by title, one by content). Critically, this paper directly confirms the central biological claim: STEAP1 expression positively correlates with AR (p<0.001), negatively trends with synaptophysin, and — like PSMA — may be lost with neuroendocrine transdifferentiation of prostate cancer.

Let me grab the remaining data artifacts to finish grounding the review.


Ran a command, ran a search
2 steps

Reading concordance and comparison tables
18 lines of output

Web Search·10.1038/s41467-023-37874-2 Nature Communications prostate ST…
9 results
Let me check the largest analytical artifact and confirm whether any explicit single-cell coverage percentages are claimed (to pin down which numbers, if any, outrun their evidence).


Scanning safety review for coverage claims
13 lines of output
I now have the complete picture. I've read the full body of work under review: the ranked target list, the PSMA×STEAP1 coverage synthesis, the combinatorial-therapy table, the scRNA-seq dataset catalog, the NOT-gate blocker survey, the AND-gate methods survey, the normal-tissue safety review, and the statistical-validation critique. Critically, I traced the provenance of every quantitative claim by pulling the source frames. Let me write the review.

## Follow-up / notes

_Which issues become committed fixes vs future work; log material changes in `docs/claude_tooling_log.md`._
